Pediatric COVID-19 in Argentina: A comprehensive analysis of disease and economic burden through official data and a systematic literature review
- Autores
- Bardach, Ariel Esteban; Ruvinsky, Silvina Denise; Moreno, Carolina; Perelli, Lucas; Kyaw, Moe H.; Spinardi, Julia; Mendoza, Carlos Fernando; Carballo, Carolina M.; Roel, Macarena; Espinola, Natalia Micaela
- Año de publicación
- 2024
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background: Limited data are available on the clinical impact and economic burden of COVID-19 in the pediatric population in Argentina. We aimed to estimate the disease and economic burden of COVID-19 on children and adolescents.Methods: We analyzed official national databases and conducted a supplemental systematic review of the published literature with meta-analysis in children aged 0-18. The period of interest was from March 2020 to August 2021, before the introduction of vaccination in this age group as a national strategic plan. In addition, we used a cost of illness analysis to estimate the direct medical costs associated with COVID-19. All costs are reported in US dollars 2023.Results: A total of 450,503 confirmed COVID-19 cases and 180 multisystem inflammatory syndrome (MIS-C) were reported in Argentina in the study period. Fourteen observational clinical studies were identified. The meta-analyses of severity level from hospital patients showed that according to different studies 15%-28% of cases were asymptomatic, 68%-88% were mild or moderate, and 3%-10% were severe or critical. About 28% of children had an underlying disease. In addition, the estimated economic burden associated with COVID-19 was 80 million dollars and 4 million dollars corresponded to MISC.Conclusion: Significant impact of COVID-19 on the healthcare system and substantial economic implications for the pediatric population in Argentina were identified. The findings should help policymakers to make informed decisions and allocate resources effectively.
Fil: Bardach, Ariel Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina. Instituto de Efectividad Clínica y Sanitaria; Argentina
Fil: Ruvinsky, Silvina Denise. Instituto de Efectividad Clínica y Sanitaria; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina
Fil: Moreno, Carolina. Instituto de Efectividad Clínica y Sanitaria; Argentina
Fil: Perelli, Lucas. Instituto de Efectividad Clínica y Sanitaria; Argentina
Fil: Kyaw, Moe H.. Pfizer Inc.; Estados Unidos
Fil: Spinardi, Julia. Pfizer Inc.; Brasil
Fil: Mendoza, Carlos Fernando. Pfizer Inc.; México
Fil: Carballo, Carolina M.. Pfizer Inc.; Argentina
Fil: Roel, Macarena. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina
Fil: Espinola, Natalia Micaela. Instituto de Efectividad Clínica y Sanitaria; Argentina - Materia
-
ARGENTINA
COVID-19
COST OF ILLNESS
META-ANALYSIS
SYSTEMATIC REVIEW - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/265117
Ver los metadatos del registro completo
id |
CONICETDig_fefc2326cb40f45d3d70c922e5c700c9 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/265117 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Pediatric COVID-19 in Argentina: A comprehensive analysis of disease and economic burden through official data and a systematic literature reviewBardach, Ariel EstebanRuvinsky, Silvina DeniseMoreno, CarolinaPerelli, LucasKyaw, Moe H.Spinardi, JuliaMendoza, Carlos FernandoCarballo, Carolina M.Roel, MacarenaEspinola, Natalia MicaelaARGENTINACOVID-19COST OF ILLNESSMETA-ANALYSISSYSTEMATIC REVIEWhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Background: Limited data are available on the clinical impact and economic burden of COVID-19 in the pediatric population in Argentina. We aimed to estimate the disease and economic burden of COVID-19 on children and adolescents.Methods: We analyzed official national databases and conducted a supplemental systematic review of the published literature with meta-analysis in children aged 0-18. The period of interest was from March 2020 to August 2021, before the introduction of vaccination in this age group as a national strategic plan. In addition, we used a cost of illness analysis to estimate the direct medical costs associated with COVID-19. All costs are reported in US dollars 2023.Results: A total of 450,503 confirmed COVID-19 cases and 180 multisystem inflammatory syndrome (MIS-C) were reported in Argentina in the study period. Fourteen observational clinical studies were identified. The meta-analyses of severity level from hospital patients showed that according to different studies 15%-28% of cases were asymptomatic, 68%-88% were mild or moderate, and 3%-10% were severe or critical. About 28% of children had an underlying disease. In addition, the estimated economic burden associated with COVID-19 was 80 million dollars and 4 million dollars corresponded to MISC.Conclusion: Significant impact of COVID-19 on the healthcare system and substantial economic implications for the pediatric population in Argentina were identified. The findings should help policymakers to make informed decisions and allocate resources effectively.Fil: Bardach, Ariel Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Ruvinsky, Silvina Denise. Instituto de Efectividad Clínica y Sanitaria; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; ArgentinaFil: Moreno, Carolina. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Perelli, Lucas. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Kyaw, Moe H.. Pfizer Inc.; Estados UnidosFil: Spinardi, Julia. Pfizer Inc.; BrasilFil: Mendoza, Carlos Fernando. Pfizer Inc.; MéxicoFil: Carballo, Carolina M.. Pfizer Inc.; ArgentinaFil: Roel, Macarena. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; ArgentinaFil: Espinola, Natalia Micaela. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFrontiers Media2024-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/265117Bardach, Ariel Esteban; Ruvinsky, Silvina Denise; Moreno, Carolina; Perelli, Lucas; Kyaw, Moe H.; et al.; Pediatric COVID-19 in Argentina: A comprehensive analysis of disease and economic burden through official data and a systematic literature review; Frontiers Media; Frontiers in Pediatrics; 12; 3-2024; 1-112296-2360CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/articles/10.3389/fped.2024.1352260/fullinfo:eu-repo/semantics/altIdentifier/doi/10.3389/fped.2024.1352260info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:48:18Zoai:ri.conicet.gov.ar:11336/265117instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:48:18.654CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Pediatric COVID-19 in Argentina: A comprehensive analysis of disease and economic burden through official data and a systematic literature review |
title |
Pediatric COVID-19 in Argentina: A comprehensive analysis of disease and economic burden through official data and a systematic literature review |
spellingShingle |
Pediatric COVID-19 in Argentina: A comprehensive analysis of disease and economic burden through official data and a systematic literature review Bardach, Ariel Esteban ARGENTINA COVID-19 COST OF ILLNESS META-ANALYSIS SYSTEMATIC REVIEW |
title_short |
Pediatric COVID-19 in Argentina: A comprehensive analysis of disease and economic burden through official data and a systematic literature review |
title_full |
Pediatric COVID-19 in Argentina: A comprehensive analysis of disease and economic burden through official data and a systematic literature review |
title_fullStr |
Pediatric COVID-19 in Argentina: A comprehensive analysis of disease and economic burden through official data and a systematic literature review |
title_full_unstemmed |
Pediatric COVID-19 in Argentina: A comprehensive analysis of disease and economic burden through official data and a systematic literature review |
title_sort |
Pediatric COVID-19 in Argentina: A comprehensive analysis of disease and economic burden through official data and a systematic literature review |
dc.creator.none.fl_str_mv |
Bardach, Ariel Esteban Ruvinsky, Silvina Denise Moreno, Carolina Perelli, Lucas Kyaw, Moe H. Spinardi, Julia Mendoza, Carlos Fernando Carballo, Carolina M. Roel, Macarena Espinola, Natalia Micaela |
author |
Bardach, Ariel Esteban |
author_facet |
Bardach, Ariel Esteban Ruvinsky, Silvina Denise Moreno, Carolina Perelli, Lucas Kyaw, Moe H. Spinardi, Julia Mendoza, Carlos Fernando Carballo, Carolina M. Roel, Macarena Espinola, Natalia Micaela |
author_role |
author |
author2 |
Ruvinsky, Silvina Denise Moreno, Carolina Perelli, Lucas Kyaw, Moe H. Spinardi, Julia Mendoza, Carlos Fernando Carballo, Carolina M. Roel, Macarena Espinola, Natalia Micaela |
author2_role |
author author author author author author author author author |
dc.subject.none.fl_str_mv |
ARGENTINA COVID-19 COST OF ILLNESS META-ANALYSIS SYSTEMATIC REVIEW |
topic |
ARGENTINA COVID-19 COST OF ILLNESS META-ANALYSIS SYSTEMATIC REVIEW |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Background: Limited data are available on the clinical impact and economic burden of COVID-19 in the pediatric population in Argentina. We aimed to estimate the disease and economic burden of COVID-19 on children and adolescents.Methods: We analyzed official national databases and conducted a supplemental systematic review of the published literature with meta-analysis in children aged 0-18. The period of interest was from March 2020 to August 2021, before the introduction of vaccination in this age group as a national strategic plan. In addition, we used a cost of illness analysis to estimate the direct medical costs associated with COVID-19. All costs are reported in US dollars 2023.Results: A total of 450,503 confirmed COVID-19 cases and 180 multisystem inflammatory syndrome (MIS-C) were reported in Argentina in the study period. Fourteen observational clinical studies were identified. The meta-analyses of severity level from hospital patients showed that according to different studies 15%-28% of cases were asymptomatic, 68%-88% were mild or moderate, and 3%-10% were severe or critical. About 28% of children had an underlying disease. In addition, the estimated economic burden associated with COVID-19 was 80 million dollars and 4 million dollars corresponded to MISC.Conclusion: Significant impact of COVID-19 on the healthcare system and substantial economic implications for the pediatric population in Argentina were identified. The findings should help policymakers to make informed decisions and allocate resources effectively. Fil: Bardach, Ariel Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Ruvinsky, Silvina Denise. Instituto de Efectividad Clínica y Sanitaria; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina Fil: Moreno, Carolina. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Perelli, Lucas. Instituto de Efectividad Clínica y Sanitaria; Argentina Fil: Kyaw, Moe H.. Pfizer Inc.; Estados Unidos Fil: Spinardi, Julia. Pfizer Inc.; Brasil Fil: Mendoza, Carlos Fernando. Pfizer Inc.; México Fil: Carballo, Carolina M.. Pfizer Inc.; Argentina Fil: Roel, Macarena. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina Fil: Espinola, Natalia Micaela. Instituto de Efectividad Clínica y Sanitaria; Argentina |
description |
Background: Limited data are available on the clinical impact and economic burden of COVID-19 in the pediatric population in Argentina. We aimed to estimate the disease and economic burden of COVID-19 on children and adolescents.Methods: We analyzed official national databases and conducted a supplemental systematic review of the published literature with meta-analysis in children aged 0-18. The period of interest was from March 2020 to August 2021, before the introduction of vaccination in this age group as a national strategic plan. In addition, we used a cost of illness analysis to estimate the direct medical costs associated with COVID-19. All costs are reported in US dollars 2023.Results: A total of 450,503 confirmed COVID-19 cases and 180 multisystem inflammatory syndrome (MIS-C) were reported in Argentina in the study period. Fourteen observational clinical studies were identified. The meta-analyses of severity level from hospital patients showed that according to different studies 15%-28% of cases were asymptomatic, 68%-88% were mild or moderate, and 3%-10% were severe or critical. About 28% of children had an underlying disease. In addition, the estimated economic burden associated with COVID-19 was 80 million dollars and 4 million dollars corresponded to MISC.Conclusion: Significant impact of COVID-19 on the healthcare system and substantial economic implications for the pediatric population in Argentina were identified. The findings should help policymakers to make informed decisions and allocate resources effectively. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-03 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/265117 Bardach, Ariel Esteban; Ruvinsky, Silvina Denise; Moreno, Carolina; Perelli, Lucas; Kyaw, Moe H.; et al.; Pediatric COVID-19 in Argentina: A comprehensive analysis of disease and economic burden through official data and a systematic literature review; Frontiers Media; Frontiers in Pediatrics; 12; 3-2024; 1-11 2296-2360 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/265117 |
identifier_str_mv |
Bardach, Ariel Esteban; Ruvinsky, Silvina Denise; Moreno, Carolina; Perelli, Lucas; Kyaw, Moe H.; et al.; Pediatric COVID-19 in Argentina: A comprehensive analysis of disease and economic burden through official data and a systematic literature review; Frontiers Media; Frontiers in Pediatrics; 12; 3-2024; 1-11 2296-2360 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/articles/10.3389/fped.2024.1352260/full info:eu-repo/semantics/altIdentifier/doi/10.3389/fped.2024.1352260 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Frontiers Media |
publisher.none.fl_str_mv |
Frontiers Media |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842268916689141760 |
score |
12.885934 |